20-44720099-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003881.4(CCN5):c.263G>A(p.Gly88Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000129 in 1,550,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003881.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCN5 | NM_003881.4 | c.263G>A | p.Gly88Glu | missense_variant | 2/4 | ENST00000190983.5 | NP_003872.1 | |
CCN5 | NM_001323370.2 | c.263G>A | p.Gly88Glu | missense_variant | 3/5 | NP_001310299.1 | ||
CCN5 | NM_001323369.2 | c.263G>A | p.Gly88Glu | missense_variant | 2/3 | NP_001310298.1 | ||
KCNK15-AS1 | NR_132377.1 | n.439-3306C>T | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000130 AC: 2AN: 154068Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 84030
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1398298Hom.: 0 Cov.: 32 AF XY: 0.00000289 AC XY: 2AN XY: 691570
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2024 | The c.263G>A (p.G88E) alteration is located in exon 2 (coding exon 2) of the WISP2 gene. This alteration results from a G to A substitution at nucleotide position 263, causing the glycine (G) at amino acid position 88 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at